Alternate service delivery models in cancer genetic counseling: a mini-review

Alternate service delivery models in cancer genetic counseling: a mini-review

Demand for cancer genetic counseling has grown rapidly in recent years as germline genomic information has become increasingly incorporated into cancer care and the field has entered the public consciousness through high-profile celebrity publications. Increased demand and existing variability in th...

Full description

Bibliographic Details
Main Authors:	Adam Hudson Buchanan, Alanna Kulchak Rahm, Janet eWilliams
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-05-01
Series:	Frontiers in Oncology
Subjects:	Comparative Effectiveness Research Genetic Counseling Telemedicine Cancer BRCA1 BRCA2
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00120/full

Similar Items

THE IMPACT OF GENETIC COUNSELING ON CLINICAL DECISION MAKING AMONG WOMEN EVALUATED FOR HEREDITARY BREAST AND OVARIAN CANCER RISK
by: PRITZLAFF, MARY ELIZABETH
Published: (2001)

The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada
by: Steven A. Narod, et al.
Published: (2021-04-01)

Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer
by: Jeanna M. McCuaig, et al.
Published: (2018-11-01)

Retrospective Comparison of In-person versus Telephone Results Disclosure Counseling for BRCA1/2 Genetic Testing
by: Doughty, Courtney R.
Published: (2008)

DNA-testing for <it>BRCA1/2</it> prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
by: Sie Aisha S, et al.
Published: (2012-05-01)

A Clinical Trial to Increase the Identification, Genetic Counseling Referral and Genetic Testing of Women at risk for Hereditary Breast and/or Ovarian Cancer
by: Ceceilia Bellcross, et al.
Published: (2017-07-01)

Genetic counselling, BRCA1/2 status and clinico-pathologic characteristics of patients with ovarian cancer before 50 years of age
by: Cvelbar Mirjam, et al.
Published: (2017-05-01)

Corrigenda for "Clinical application of multigene panels: challenges of next-generation counseling and cancer risk management".
by: Thomas Paul Slavin
Published: (2015-12-01)

A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
by: Forbes C, et al.
Published: (2019-03-01)

BRCA1 and BRCA2 mutation spectrum – an update on mutation distribution in a large cancer genetics clinic in Norway
by: Cecilie Heramb, et al.
Published: (2018-01-01)

Increasing confidence and changing behaviors in primary care providers engaged in genetic counselling
by: Michael S. Wilkes, et al.
Published: (2017-09-01)

Hereditary breast and ovarian cancer in Andalusian families: a genetic population study
by: Bella Pajares, et al.
Published: (2018-06-01)

Genetics of breast cancer: Applications to the Mexican population
by: Elad Ziv
Published: (2011-10-01)

Predisposición genética para el cáncer de mama: genes BRCA1 y BRCA2 Genetic predisposition for breast cancer: BRCA1 and BRCA2 genes
by: Steven A Narod, et al.
Published: (2011-10-01)

Tools and Strategies That a BRCA Positive Population Considers to be Useful in the Result Disclosure Process to Family Members
by: Snyder, Justine A., B.A.
Published: (2012)

Factors predicting <i>BRCA1</i> and <i>BRCA2</i> mutation carriers’ preference for communication of risk estimates.
by: Crowdes, Sophie Rose
Published: (2016)

Cáncer de mama y ovario hereditario:consejo genético, seguimiento y reducción del riesgo
by: Begoña Graña, et al.
Published: (2005-01-01)

Characteristics of breast cancer in BRCA1/BRCA2 mutation carriers and non-carriersfrom a genetic counseling unit in Croatia
by: Snježana Ramić, et al.
Published: (2020-01-01)

Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
by: Seth K. Rummel, et al.
Published: (2020-01-01)

Exploring Predictors of Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer: Findings from the 2015 U.S. National Health Interview Survey
by: Caitlin G. Allen, et al.
Published: (2019-05-01)

MEDICAL AND GENETIC COUNSELING OF HEREDITARY BREAST AND OVARIAN CANCER
by: S. A. Laptiev, et al.
Published: (2018-06-01)

Prédispositions génétiques au cancer du sein et de l'ovaire dans la population suisse entre 1996 et 2009 : bilan de l'activité oncogénétique et du dépistage de mutations constitutionnelles dans les gènes BRCA1/BRCA2
by: Ayme, Aurélie
Published: (2013)

Pediatric reporting of genomic results study (PROGRESS): a mixed-methods, longitudinal, observational cohort study protocol to explore disclosure of actionable adult- and pediatric-onset genomic variants to minors and their parents
by: Juliann M. Savatt, et al.
Published: (2020-05-01)

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
by: Hakyoung Kim, et al.
Published: (2019-01-01)

How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer
by: Watts Kaaren J, et al.
Published: (2012-07-01)

The Pathology of Hereditary Breast Cancer
by: Honrado Emiliano, et al.
Published: (2004-07-01)

Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study
by: Sara Mella, et al.
Published: (2017-10-01)

Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw
by: Dominik Olejniczak, et al.
Published: (2016-03-01)

Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia
by: Lucie G. Hallenstein, et al.
Published: (2021-02-01)

The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
by: S V Khokhlova
Published: (2016-12-01)

Olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
by: S V Khokhlova
Published: (2017-09-01)

Age of natural menopause onset in BRCA1/2 carriers – systematic review and meta-analysis
by: Łukasz Kępczyński, et al.
Published: (2021-01-01)

Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice
by: Bettina Meiser, et al.
Published: (2021-04-01)

Hereditary breast cancer: genetic and clinical hetergeneity, genetic testing, prophylactic surgery
by: L. N. Lyubchenko, et al.
Published: (2015-06-01)

Genetics of breast cancer: Contribution of BRCA1/2 genes alterations to hereditary predisposition
by: Branković-Magić Mirjana, et al.
Published: (2012-01-01)

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
by: Athanasios Pouptsis, et al.
Published: (2020-10-01)

What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?
by: Elmira Ebrahimi, et al.
Published: (2018-11-01)

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study
by: Priyanka Bobbili, et al.
Published: (2020-06-01)

The role of BRCA1/2 in hereditary and familial breast and ovarian cancers
by: Yousef M. Hawsawi, et al.
Published: (2019-09-01)

Determinação de mutações e polimorfismo nos genes BRCA1 e BRCA2 em pacientes com câncer de mama com indicação para teste genético
by: Karina Augusto Escobar
Published: (2011)